As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: August 10, 2012
by Megan Gannon for Live Science:
Researchers have some reassuring news for women who suffer from migraines: There is no strong link between the intensely painful headaches and cognitive decline or dementia.
The research out of Brigham and Women’s Hospital in Boston is based on data from 6,349 women ages 45 and older who participated in a health survey. The participants were classified into four groups: no history of migraine, past history of migraine, and continued history of migraine with and without aura. (Auras can cause a person to see flashes of light or feel pins-and-needles sensations before a migraine kicks in.)
After this baseline information was collection, the participants were tested for cognitive function in two-year intervals up to three times. The results, which were published online Aug. 8 in the British Medical Journal, showed no strong relationship between migraines and long-term consequences on cognition, according to the researchers.
“Compared with women with no history of migraine, those who experienced migraine with or without aura did not have significantly different rates of cognitive decline,” Pamela Rist, who led the study, explained in a statement from Brigham and Women’s Hospital.
“Previous studies on migraines and cognitive decline were small and unable to identify a link between the two,” Rist added. “Our study was large enough to draw the conclusion that migraines, while painful, are not strongly linked to cognitive decline.”
About 30 million Americans suffer from migraines, but women are three times more likely than men to be impacted by them. The debilitating headaches have been linked to an increased risk of depression and even stroke. Much is still unknown about the chronic condition, but researchers recently found the first genetic link to migraines — a gene variant also found to change the activity of other genes, including one previously linked to disorders such as epilepsy.
Thirty-six million people worldwide suffer from Alzheimer’s disease and dementia. In Canada, 25,000 new cases are diagnosed each year. Those sobering numbers have researchers around the globe racing to come up with new ways to...
he Food and Drug Administration issued new guides on drug development for neurological disorders. This sets the stage for possible treatments for Alzheimer’s. The disease-oriented development guide documents will provide details on how researchers...
For young adults with autosomal dominant Alzheimer’s disease (AD), molecular markers can identify changes associated with the disease before clinical onset, according to a study published online Feb. 12 in JAMA Neurology. Yakeel T. Quiroz, Ph.D., from Massachusetts...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.